/ Not yet recruitingPhase 2IIT A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males, to pinpoint sensitive indicators of human senescence, and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging.
/ CompletedNot Applicable A Multi-center, Retrospective, Registry Study to Estimate the Current Status of Patients With Non-Obstructive coroNary Artery Disease (CAD) Confirmed Via Coronary Angiography (CAG) (RESPOND Study)
The study will estimate the current status of participants with non-obstructive coronary artery disease confirmed via coronary angiography.
A Single-arm, Interventional, Multi-center, Pilot Study to Evaluate the Efficacy of Oral Bisoprolol on Heart Rate Reduction in Chinese Chronic Heart Failure Patients With NYHA Class II - IV (Biso-CHF Study)
This is a single-arm, open label, interventional, multi-center, phase 4 pilot study.
100 Clinical Results associated with Merck Serono Co., Ltd. (China)
0 Patents (Medical) associated with Merck Serono Co., Ltd. (China)
100 Deals associated with Merck Serono Co., Ltd. (China)
100 Translational Medicine associated with Merck Serono Co., Ltd. (China)